INFI - Infinity Pharmaceuticals Inc. (INFI) CEO Adelene Perkins on Q3 2021 Results - Earnings Call Transcript

Infinity Pharmaceuticals, Inc. (INFI) Q3 2021 Earnings Conference Call November 2, 2021 4:30 PM ET Company Participants Jayne Kauffman - Senior Administrative Manager Adelene Perkins - Chair and Chief Executive Officer Robert Ilaria - Chief Medical Officer Larry Bloch - President Conference Call Participants Anupam Rama - J.P. Morgan Kevin DeGeeter - Oppenheimer Ed Tenthoff - Piper Sandler Nick Abbott - Wells Fargo Securities, LLC Michael King - H.C. Wainwright & Co. Kalpit Patel - B Riley Securities Soumit Roy - Jones Research Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Infinity Pharmaceuticals Conference Call to discuss the company's Operations and Third Quarter 2021 Financial Results. My name is Tina, and I'll be your operator for today's call. [Operator Instructions] Please be advised that this call is being recorded at Infinity's request. Now I would like to introduce your host for today's call, Jayne Kauffman.

For further details see:

Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q3 2021 Results - Earnings Call Transcript